Abstract:Cyclosporine is a preferred calcineurin inhibitor that is considered to be the backbone of current immunosuppressive drug therapy. The aim of this study was to build a population pharmacokinetics (Pop-Pk) cyclosporine model in renal transplant recipients and identify the influence of a range of potential covariates, including genetic polymorphisms that affect cyclosporine pharmacokinetic parameters. The analysis was performed with 1051 retrospective drug monitoring data points in 80 renal recipients receiving cyclosporine-based immunosuppressive therapy. Clinical characteristics were collected for up to 28 postoperative days. CYP3A4* 18B, CYP3A5*3, ABCB1 C1236T, G2677T/A, and C3435T genotyping was performed. A Pop-Pk model was developed using a nonlinear mixed effects modeling (NONMEM) program. After building the final model, 1000 bootstraps were performed to validate the final model. A one-compartment open model with first-order absorption and elimination was chosen to describe the pharmacokinetics of cyclosporine. The Pop-Pk analysis showed that postoperative days, weight, direct bilirubin and hematocrit, significantly affected the pharmacokinetics of cyclosporine. The final model with the clearance covariates was presented as: Cl/F = 60.7 x POD-(0.41) x(DBIL/4.6)(-0.11) x (WT/60)(0.31) x (HCT/33)(-0.24) (Lxh(-1)), and the final model with the volume covariates was presented as: Vd/F=348xPOD(-0.39) (L). The CYP3A4* 18B, CYP3A5*3, ABCB1 C1236T, G2677T/A, and C3435T genotypes were not identified as having significant effect on the cyclosporine pharmacokinetic parameters. The model will help to calculate cyclosporine dose requirements in renal transplant recipients according to specific clinical factors affecting the cyclosporine clearance. It will also be useful in individual cyclosporine pharmacotherapy for renal transplantation patients, to achieve the desired therapeutic target.

Population Pharmacokinetics of Ciclosporin in Chinese Children with Aplastic Anemia: Effects of Weight, Renal Function and Stanozolol Administration

Age Difference of Cyclosporin Dosage in Pediatric Patients

Population Pharmacokinetics of Cyclosporine in Chinese Children Receiving Hematopoietic Stem Cell Transplantation

Initial dosage optimization of ciclosporin in pediatric Chinese patients who underwent bone marrow transplants based on population pharmacokinetics.

Population Pharmacokinetic Study Of Cyclosporine In Hematopoietic Stem Cell Transplant Recipients

Population Pharmacokinetics of Cyclosporine A in Chinese Patients with Nephrotic Syndrome in Individualized Drug Administration

Population Pharmacokinetics Of Cyclosporine In Clinical Renal Transplant Patients

No Effect of Genetic Polymorphisms on Cyclosporine Pharmacokinetics in Renal Transplant Recipients Based on Nonlinear Mixed Effects Modeling

Population pharmacokinetics of cyclosporine A in hematopoietic stem cell transplant recipients: A systematic review

Time-dependent Clearance of Cyclosporine in Adult Renal Transplant Recipients: A Population Pharmacokinetic Perspective

Population Pharmacokinetics and Dosage Optimization of Tacrolimus in Pediatric Patients with Nephrotic Syndrome

Population Pharmacokinetic Study of Cyclosporine and Its Application

Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese pediatric hematopoietic stem cell transplantation patients

Population Pharmacokinetic Characteristics of Sirolimus in Healthy Chinese Subjects and Renal Transplant Patients

Population pharmacokinetics and initial dosing regimen optimization of cyclosporin in pediatric hemophagocytic lymphohistiocytosis patients

Population pharmacokinetics and dosing regimen optimisation of tacrolimus in Chinese pediatric hematopoietic stem cell transplantation patients.

Population Pharmacokinetics and Initial Dosage Optimization of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Patients

Population Pharmacokinetics and Pharmacogenomics of Tacrolimus in Chinese Children Receiving a Liver Transplant: Initial Dose Recommendation

Population Pharmacokinetics of Tacrolimus in Chinese Pediatric Patients with Nephrotic Syndrome

Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome

Population Pharmacokinetics Model and Initial Dose Optimization of Tacrolimus in Children and Adolescents with Lupus Nephritis Based on Real-World Data